-
Document de presse | 2024.04.26
Bronchiolitis: two French studies demonstrate the effectiveness of Beyfortus® in preventing serious illness and reducing hospital admissions among infants
After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunization campaign, administering nirsevimab (Beyfortus®), to protect infants and reduce the circulation of the virus.To assess the...
-
News | 2022.10.05
A series of events to mark the bicentenary of Louis Pasteur’s birth
The Institut Pasteur is continuing to celebrate the bicentenary of Louis Pasteur's birth by organizing a major conference in December and also by partnering with events organized by other institutions and participating in official 2022 bicentenary festivals and conferences. Check out the calendar of events below and at www.pasteur2022.fr.
-
News | 2024.07.03
A look back at Pasteur Innov' Day 2024 : a hugely successful 2nd edition !
On June 25, 2024, the Institut Pasteur hosted the second edition of Pasteur Innov'Day. The goal was to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector. The event was attended by almost 150 partners (startups, SMEs, major pharmaceutical corporations, investors, and other innovation stakeholders) as well as many Institut...
-
News | 2022.12.27
Bicentenary of Louis Pasteur's birth: looking back on a year of commemorations
Two hundred years ago, on December 27, 1822, Louis Pasteur was born in the town of Dole, in the Jura region of France. The year 2022 was an opportunity to celebrate Louis Pasteur's scientific and cultural legacy and to give people a chance to discover – or rediscover – his life and work.
-
News | 2025.03.20
An international scientific alliance to strengthen the fight against infectious diseases
The Institut Pasteur and UCSF-QBI celebrated an ongoing successful scientific collaboration today, which was initiated in March 2019, and expanded significantly during the pandemic. This alliance, formalized in October 2022, aimed at bolstering the fight against infectious diseases, has already spawned more than 20 research projects, a dozen publications in high-level journals, and numerous...
-
Article | 2023.02.23
One Health-Emerging Infectious Diseases Graduate School (1H-EID)
The new Graduate School "One Health in Emerging Infectious Diseases" (1H-EID) is entirely dedicated to EIDs with a multidisciplinary approach. This Graduate School offers a high-level educational program based on research, to train future researchers, health professionals and decision-makers.The aim of 1H-EID will be to form a community of frontline actors, researchers and decision-makers,all...
-
News | 2020.12.07
Unprecedented solidarity and support to accompany the member institutes of the International Network in the face of the COVID-19 pandemic
The Institut Pasteur International Network, with the support of the International Department of the Institut Pasteur (Paris) and in association with institutional funders, has mobilised to help certain member institutes in Africa and Asia to carry out their public health missions in the context of the management of the COVID-19 pandemic. The objective of this aid was to provide them with...
-
Article | 2023.04.04
4-year Research Group - Call for nomination at the Pasteur Fiocruz Center
A 4-year Group leaders’ position is open at the Pasteur Fiocruz Center on Immunology and Immunotherapy
-
News | 2019.02.21
A research ethics committee at the Institut Pasteur since 2009
The Institut Pasteur Institutional Review Board (IRB) protects the rights and safety of participants in research carried out by the Institut Pasteur abroad. Since it was set up in 2009, it has monitored nearly 50 international research projects involving human subjects. The Board is currently chaired by Dr. Gilles Raguin, a physician specializing in infectious diseases. We asked him to tell us...
-
News | 2020.05.20
Blood test: a potential new tool for controlling infections
A new technique could provide vital information about a community’s immunity to infectious diseases including malaria and Covid-19.The diagnostic test analyses a blood sample to reveal immune markers that indicate whether – and when – a person was exposed to an infection. It was developed to track malaria infections in communities, to assist in the elimination of deadly ‘relapsing’ malaria, but...